Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Journal of Cardiovascular Pharmacology|July 1, 2010
Standard versus low-dose transdermal nitroglycerin: differential effects on the development of tolerance and abnormalities of endothelial functionAmar Uxa, George R Thomas, Tommaso Gori, et al.Journal of the American College of Cardiology|March 31, 2007
Once daily therapy with isosorbide-5-mononitrate causes endothelial dysfunction in humans: evidence of a free-radical-mediated mechanismGeorge R Thomas, Jonathan M DiFabio, Tommaso Gori, et al.Viruses|February 27, 2026
A Polinton-like Virus of C. parva Inhibits the Population Growth of a Newly Isolated Relative of Tethysvirus ontarioenseGeorge R Thomas, Ichiro Inamoto, Christine N Palermo, et al.Canadian Journal of Physiology and Pharmacology|June 16, 2009
Continuous therapy with transdermal nitroglycerin does not affect biomarkers of vascular inflammation and injury in healthy volunteersGeorge R Thomas, Jonathan M DiFabio, Tommaso Gori, et al.Canadian Journal of Physiology and Pharmacology|March 6, 2014
Pyridoxal-5'-phosphate (MC-1), a vitamin B6 derivative, inhibits expressed P2X receptorsOlivier Thériault, Hugo Poulin, George R Thomas, et al.The Journal of Pharmacology and Experimental Therapeutics|April 20, 2006
Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survivalJonathan M DiFabio, George R Thomas, Liana Zucco, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2014
Multicenter randomized phase 2 clinical trial of a recombinant human endostatin adenovirus in patients with advanced head and neck carcinomaWen Ye, Ranyi Liu, Changchuan Pan, et al.Pageof 1